ELISA procedures for the quantitation of glutathione transferases in the urine  by Sundberg, Anders G.M. et al.
Kidney International, Vol. 48 (1995), pp 570—575
TECHNICAL NOTE
ELISA procedures for the quantitation of glutathione
transferases in the urine
ANDERS G.M. SUNDBERG, ROBERT NlLssoN, EEvA-LIIsA APPELKVIST, and GUSTAV DALLNER
Division of Medical Cell Biology, Clinical Research Center, Novum, Karolinska Institutet, Huddinge, Sweden
ELISA procedures for the quantitation of glutathione transferases in
the urine. The proximal portion of the human kidney tubular system
contains the a form, while the distal portion contains the r form of
glutathione transferase. These cytoplasmic proteins are released into the
urine under pathological conditions, and an ELISA procedure has been
developed for their quantitation. Optimal conditions with respect to
concentrations of antibody and antigen and incubation times were deter-
mined. The procedure developed can detect as little as 0.5 ng enzyme per
ml urine, even in the presence of high concentrations of other proteins. No
cross reaction between these two isoenzymes or with a number of other
proteins in the urine was observed. Antibodies interacted with these
antigens in urine samples in the same manner as they interacted with the
purified proteins. Storage of samples without loss of antigen required the
presence of low concentrations of detergent, such as Tween 20, which both
stabilized the enzymes and prevented their adsorption to the walls of the
plastic tubes. The results indicate that increased urinary levels of these two
enzyme proteins, as determined by the ELISA procedure, are useful
markers for tubular damage.
Glutathione transferases (GST) demonstrate a broad distribu-
tion in the body, being present in all organs [1—4]. On the other
hand, the tissue and cellular localizations of certain isoenzymes of
this protein are highly specific. The large majority of the glutathi-
one transferases are present in the cytosol, and the three groups
best characterized to date are the a, and p. forms [5, 6].
The glutathione transferases in human kidney demonstrate
specific distributions, with the a form being present only in the
proximal tubular system, whereas the ii form is associated with the
distal tubular regions and the collecting ducts [7—9]. GST in the
cytoplasm may account for as much as 2 to 3% of the total
cytoplasmic protein [3], and an abnormal increase in cell mem-
brane permeability results in the appearance of these molecules in
the extracellular space. Appearance of enzyme proteins in the
urine might serve as a basis for the development of diagnostic
markers for renal disease and/or damage [10, 11]. Applying a
radioimmunoassay (RIA) procedure, we could monitor elevated
levels of OST in the urine and establish that certain patterns of
excretion are characteristic for certain pathological conditions [12,
13].
Thus, release of GST appears to be a suitable indicator for
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processes damaging the tubular epithelium of the kidney, and it
seems reasonable that measurement of GST in the urine may
provide a diagnostic test similar to those employed for heart and
liver damage. Our purpose here was to develop an ELISA
procedure for relatively rapid estimation of GST concentrations
in the urine.
Methods
Class a and glutathione transferases were purified from
normal human liver and full term placenta, respectively [14, 15].
During the purification procedure the enzyme activities were
measured according to Habig, Pabst and Jakoby [16], and the
protein was quantitated by the method of Lowry et al [17]. The
purity of the proteins was confirmed by SDS-PAGE according to
Laemmli [18]. Single bands at 27,000 and 25,000 Daltons were
obtained with the GST a and ir preparations, respectively.
Antibodies were produced in New Zealand white rabbits weigh-
ing 3 kg. Purified enzyme antigens suspended in Freund's com-
plete adjuvant (GIBCO) were injected intramuscularly, followed
by booster injections of the enzyme in Freund's incomplete
adjuvant several times at three-week intervals. Ten days after the
last booster injection, blood was tapped and allowed to coagulate.
For preparation of monospecific antibodies the purified GST a
and r proteins were coupled to CNBr-activated Sepharose 4B
(Pharmacia, Uppsala, Sweden). The corresponding serum was
applied to the appropriate column and extensively washed with
0.05 M phosphate-buffered saline (PBS) in order to remove all
non-bound proteins. The antibodies were eluted with 3 M
NH4SCN in PBS and immediately dialyzed against PBS and
concentrated in an Amicon Centriprep tube. The protein concen-
tration was adjusted to about 1 to 2 mg/mI for the pure anti-GST
antibodies. Purified antibodies were stored in PBS at —70°C.
Western blot analysis was performed according to Towbin, Stae-
helm and Gordon [19]. This procedure was employed to control
the specificities of the antibodies toward proteins in homogenates
from liver, kidney, lung and adrenal, as well as in blood plasma,
hemolysate of erythrocytes, cerebrospinal fluid and urine.
To produce antibody conjugate the purified antibody was mixed
with a solution of calf intestinal alkaline phosphatase (Sigma, St.
Louis, MO, USA) at a protein ratio of 1:3 in PBS. Glutaraldehyde
was added as the cross-linking agent at a final concentration of
0.2%. After two hours of incubation at room temperature, the
mixture was dialyzed against Tris-Cl, pH 7.6, to remove excess
glutaraldehyde and phosphate buffer which might otherwise result
in product inhibition. The conjugate was supplemented with 1%
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bovine serum albumin (BSA) and 0.02% sodium azide and
thereafter stored at + 4°C.
The microtiter plates selected for routine analysis were Maxi-
sorp C (Nunc, Roskilde, Denmark). The wells were coated with 50
p1 antibody (anti-a or -ir) in 0.05 M carbonate-bicarbonate buffer,
pH 9.6. The protein concentration in the medium was 3 g/ml.
The plates were then kept refrigerated overnight. The wells were
washed three times with a buffer consisting of 0.05 M Tris-Ci, pH
7.6, with 0.9% NaC1 and 0.1% Tween 20. The wells were then
filled completely with washing buffer containing 1% BSA in order
to block remaining binding sites not occupied by antibody. After
one hour all wells were again washed three times with the washing
buffer. The antibody coated plates were stored at + 4°C.
All samples were supplemented during collection with buffer to
give a final concentration of 0.05 M Tris-Cl, pH 7.6, and 0.05%
Tween 20 and 100 pi of this sample mixture were applied to each
well. Incubation was performed at room temperature for three
hours. After incubation, all wells were washed three times with
washing buffer supplemented with 0.5% BSA. For quantitation of
the bound antigen, 100 td antibody conjugate was added to each
well and incubated for one hour at room temperature. All wells
were thereafter thoroughly washed five times with the washing
buffer to remove all non-specifically bound antibody conjugate.
Bound alkaline phosphatase activity was determined by adding
100 p1 p-nitrophenylphosphate, 1.0 mglml, in diethanolamine
buffer, pH 10.6. After incubation at room temperature, the
colored product was quantitated at 405 nm in an Anthos HT2
microplate reader. Simultaneous measurement at 620 nm (as a
reference wavelength) was performed.
Plastic tubes adsorb proteins and, consequently, reduce the
content of free GST in the sample. To counteract this adsorption,
all tubes were routinely supplemented with a buffer consisting of
1 M Tris-Cl, pH 7.6, 20% BSA, 1% Tween 20 and 0.05% sodium
azide before the addition of sample. A 10 ml sample was added to
the tube containing 500 p1 of this buffer.
To confirm the validity of the ELISA procedure developed
here, urine samples from patients with well defined pathological
conditions were examined. Control samples were from healthy
adults participating in a health control program. Pathological
samples were collected from patients who had received renal
allografts. Three different pathological conditions in this patient
group were studied: cyclosporine A-induced nephrotoxicity, renal
infarction and acute rejection of renal allografts. The details of
the clinical diagnoses, the criteria used for these pathological
processes, and treatment of the patients was very similar to that
described in detail in a previous paper [13].
Results
GST a and ir were purified to homogeneity. The purification
factors, from the cytosolic fraction to the final preparation, were
66 for GST a and 366 for GST ir. The yields were 4 to 5% forboth
enzymes. Upon SDS-PAGE both the a and ir GSTs appeared as
single bands with apparent molecular weights of 27 and 25 kD,
respectively.
Western blot analysis demonstrated the specificities of the
antisera. Single bands were observed when a mixture of purified
GST a and ir were allowed to react with antibodies towards either
GST a or r (Fig. 1 A, B). A supernatant fraction was also
prepared from the total homogenate of human kidney, which is
Fig. 1. Western blot analyses of the GST proteins. A. Western blot using
antibodies towards GST a. Lane 1, cytosol from total human kidney
homogenate; lane 2, purified GST a from human liver. B. Western blot
using antibodies towards OST ir. Lane 1, cytosol from total human kidney
homogenate; lane 2, purified GST ir from human placenta.
known to contain both these isoenzymes [9, 20]. Western blot
analysis of this fraction using either anti-a or - antibodies
revealed only a single band with the proper molecular weight (Fig.
1 A, B).
The hydrophobic properties of the antibodies employed make it
necessary to select appropriate microtiter plates. We tested a
large number of different plates and considerable differences were
observed. When three types of polystyrene plastic plates from the
same producer were coated with the same antibodies towards
GST a, subsequent quantitation of GST a by the ELISA proce-
dure gave different results (Fig. 2). In fact, adsorption of the
antibody to one of these plates was one-third higher than to the
other two. Thus, the selection of appropriate plastic material is of
importance.
Optimal binding capacity for GST antigens was achieved when
the microtiter plates were coated with antibody in a concentration
of 3 g/ml. To get maximal binding of GST antigens to the
antibody coated plates, a minimum of two hours incubation at
room temperature was required.
Our main purpose for developing the ELISA procedure de-
scribed here is for the determination of GST excretion in the
urine. It is well known that the pH of urine varies, even under
normal physiological conditions, between 4.5 and 8.2. For this
reason it was necessary to determine to what extent the pH value
influences the antigen-antibody interaction during the quantita-
tion procedure. This interaction was thus examined between pH 3
and 11 using appropriate buffers. In the case of GST a, optimal
interaction was obtained between pH 6 and 10 (Fig. 3A). In a
similar experiment optimal interaction with GST ir was obtained
between pH 5 and 9 (Fig. 3B). It is apparent that the antigen-
antibody interactions involved demonstrate broad pH optima.
Various buffers in this pH range were also used, and it was found
that the interaction was exclusively dependent on the pH itself and
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Fig. 2. Comparison of the performance of different microtiter plates in the
ELISA procedure for GST a. Three types of polystyrene plates, ([I])
Maxisorp C, (A) Polysorp C, and (0) Polysorp F from NUNC Co.
(Copenhagen, Denmark), were employed. All plates were coated with 50
gl anti-OST a at a concentration of 3 gg/ml. After reaction with a serial
dilution of GST a, the samples were incubated with the same concentra-
tion of antibody conjugate.
it was not influenced by the nature of the buffer used. Thus, this
experiment demonstrates the necessity of maintaining an appro-
priate pH value during the ELISA procedure.
Alkaline phosphatase was bound to the detector antibodies and
the hydrolytic action of this enzyme was inhibited by one of the
reaction products, that is, orthophosphate. To avoid such inhibi-
tion, no phosphate buffers were used in the procedure. Routinely,
all sample and conjugate incubations, as well as washes, were
performed with Tris buffers.
The procedure described here was devised partially for sensitive
detection of enzyme antigens and partially to allow quantitation of
these proteins at both low and high concentrations. As seen in
Table 1, both the a and ir enzymes in the urine could be
quantitated even when the samples were supplemented with
various amounts of purified GST. Reliable quantitation was thus
achieved not only with a low level of antigen, but even when this
level was increased 20- to 80-fold.
The validity of the test was also examined by comparing the
concentration dependence of the interaction between the anti-
bodies and the pure protein or the same protein excreted in the
urine. Using serial dilutions, typical sigmoidal patterns of inter-
action were obtained with both the a (Fig. 4A) and ir forms (Fig.
4B). When urine samples diluted in the same manner were
subjected to analysis, a parallel pattern of interaction was ob-
served. Thus, these results indicate that the enzyme excreted in
the urine possesses the same immunochemical properties as the
purified proteins and, furthermore, that no factors which interfere
with the interaction between antigen and antibody are present in
the urine.
Under pathological conditions human urine may contain a
number of various types of proteins, originating both from the
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Fig. 3. Influence of pH on antigen-antibody interaction in the ELISA
procedure. A. OST a was dissolved at a concentration of 20 ngfml in 0.05
M sodium citrate (pH 3 to 6), Tris-maleate (pH 6 to 8), Tris-CI (pH 8 to
9) or carbonate-bicarbonate (pH 9 to 11). ELISA was then performed as
described in the Methods section. B. As in A, except that GST r was used
as the antigen.
blood and from the kidney itself. The possible influence of such
proteins on the ELISA procedure was therefore investigated. The
ELISA developed here exhibits a high degree of specificity and no
cross reaction between OST a and ii- is observed (Table 2). In
addition, proteins that may appear in the urine, such as albumin,
IgG, fibrinogen, prothrombin, hemoglobin and p2-microglobulin,
give no response in the ELISA test for GST a and ir.
Routinely all samples were analyzed in duplicate and the
variation coefficient typically did not exceed 5%. Also, the inter-
assay reproducibility upon repeated measurements of the same
sample were within a 5% range.
Urine samples are routinely stored in plastic tubes, which may
create problems. In all types of plastic tubes which we tested,
considerable adsorption of proteins to the tube wall occurs. The
purified GST proteins were diluted in Tris-buffer and added to
ordinary polystyrene test tubes. As early as after two hours of
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GST a ng/ml GST ir ng/ml
Recovered in the Recovered in the
Added urine sample Added urine sample
0 1.2 0 5.0
10 11.0 10 15.3
30 31.3 30 35.8
70 71.2 70 75.5
90 92.5 90 95.6
incubation at + 37°C, 30% ofGST a (Fig. 5A) and 80% of GST ir
(Fig. 5B) had been removed from the sample by adsorption.
When the samples were supplemented with the detergent Tween
20, even at low concentrations, this adsorption was counteracted
and the total amount of enzyme protein present in the samples
could be measured. Furthermore, these experiments also indicate
that this detergent does not disturb the antigen-antibody interac-
tion, since identical values were obtained even when as much as
5% Tween 20 was present in the reaction mixture.
Storage of the samples at —18, +4 and + 20°C for 10 days did
not decrease the detectable enzyme amounts to any appreciable
extent. If the samples were stored at room temperature at pH 4.5,
7.0 or 8.5 the measurable amounts of GST r decreased only by 15
to 25% after 10 days. The GST a containing urine could be stored
at pH 7.0 or 8.5, however, at pH 4.5 only 25% was detectable after
10 days.
As a preliminary study on the usefulness of this procedure, the
OST contents in the urine of patients demonstrating several
well-established pathological processes were analyzed and a few
typical cases were selected. In the urine of healthy individuals the
a form is present at a concentration of 0.9 ng/ml, while the
corresponding value for the ir enzyme is around 5.2 ng/ml (Table
3). In connection with cyclosporine A (C5A)-induced nephrotox-
icity, which affects the proximal tubular system, the a, but not the
form is excreted in elevated amounts. During renal infarction,
when all or part of the kidney is damaged, both enzymes are
excreted at highly elevated levels. In association with acute
rejection of renal allografts after kidney transplantation, the ir,
but not the a form is excreted into the urine in high concentra-
tions. The same samples which were analyzed with the ELISA
procedure were also investigated with the RIA procedure previ-
ously described by us [121. As it appears in Table 3, no major
differences were seen. Clearly, the ELISA procedure described
here can be used to detect the release of GST from tubular cells
and, thus, be employed for diagnostic purposes.
Discussion
Earlier investigations have demonstrated that quantitation of
urinary GST is a useful diagnostic tool [10, 13]. It was found that
in connection with CsA-induced nephrotoxicity in patients receiv-
ing renal allografts, the a form is excreted in elevated amounts,
which is not the case during acute rejection. On the other hand,
the ir protein is found at elevated levels in the urine during
rejection, but not in connection with CsA toxicity. Also, certain
000001 0.001 0.01 0.1 1
Dilution of standard and sample
Fig. 4. Comparison of the ELISA procedure using (II]) purified GSTor (A)
human urine. A. Purified GST a was diluted in buffer as described in the
Methods section. Samples consisted of human urine containing both
enzymes. A series of dilutions were tested in the ELISA procedure. B. As
in A, except that purified GST r was employed.
antibiotics and heavy metals which damage the tubular system
cause elevated excretion of OST L10, 21]. Previous studies by
others and our own experiments indicate that no total necrosis is
required for enzymuria since plasma membrane damage can
occur without cell death [221. Preliminary results indicate that
even when UST levels in blood plasma are high, such as in
hepatitis, no elevated enzyme levels are seen in urine.
The ELISA procedure has considerable advantages over RIA.
No radioactive label is required, which means that the period
during which the same preparation of antigen can be used is
greatly extended. It is also easier to perform a large number of
Table 1. Quantitation of GST a and r added in different amounts to
human urine A
The urine samples from healthy adults were analyzed after addition of
the indicated amounts of purified OST a or ir. These values are the means
of three determinations.
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Table 2. Cross reactions of different human proteins in the ELISA
procedure employed
ELISA procedures for
optical density 405 nm
Protein added Amount/mi GST a GST r
None 0.097 0.003 0.098 0.004
GST a 20 ng 2.435 0.087 0.095 0.005
GST r 20 ng 0.098 0.01 2.201 0.077
GST s 1000 ng 0.097 0.004 0.099 0.003
Albumin 50mg 0.099 0.004 0.099 0.003
IgG 15 mg 0.101 0.004 0.096 0.003
Fibrinogen 4mg 0.098 0.005 0.097 0.004
Prothrombin 140 sg 0.096 0.003 0.100 0.004
Hemoglobin 150mg 0.099 0.003 0.100 0.004
j32-microglobulin 200 sg 0.099 0.004 0.096 0.003
The samples were analyzed with the ELISA procedures for both GST a
and r. The proteins were dissolved in 0.05 M Tris-Cl, pH 7.6, 0.9% NaCl
and 0.05% Tween 20 and added to give the concentrations shown in the
table. The values are mean SCM (N = 6).
measurements and the procedure is more sensitive, less time-
consuming and less expensive. The ELISA procedure is able to
quantitate as low concentrations of GSTs as 0.5 ng/ml, and the
entire procedure can be performed in less than five hours.
The enzymes which we have studied here were purified to a
high degree of homogeneity and, consequently, the antibodies
obtained were monospecific. The test therefore exhibited a high
level of specificity: antibodies directed towards GST a and r did
not cross react and, in addition, other proteins occasionally
present in the urine under different conditions did not interfere
with the ELISA employed.
The pH optimum for measurement with this procedure is
broad, that is, pH 6 to 9, and consequently, no problems arise with
samples in this range. However, since many urine samples are
more acidic than pH 6, it is necessary to add appropriate buffers
before measurement. The proteins in the current study's samples
exhibited the same behavior as purified GSTs and, furthermore,
the interaction between antigen and antibody was not influenced
by other components present in urine. The procedure also proved
to be sensitive, allowing detection of 0.5 ng antigen per ml. This
procedure is suitable not only for measuring small amounts of
protein, but also when the protein level is high, that is, the
procedure is reliable over a wide range of protein concentrations.
Storage is one of the most important practical aspects of urine
analysis. When samples are taken from humans, analyses are
usually not performed immediately. If the protein to be analyzed
is not sufficiently stable during such storage, its level cannot be
reliably determined. From this point of view, GSTs are almost
ideal proteins. These enzymes are stable not only at —18°C, but
also at + 4°C; even at room temperature 90% of the protein is
immunochemically detectable after 10 days of storage. The pH of
human urine displays great variations even under normal physio-
logical conditions. Such variations during storage do not, however,
influence the analytical procedure developed here, since after
storage of the r enzyme between pH 4.5 and 8.5 practically the
same values were obtained. The a form is, however, sensitive to
storage at acidic pH. Appropriate buffering of the sample before
storage is therefore of importance in this case.
A more serious problem is the plastic material of the the tubes
used for storage of samples, as well as the microtiter plates used
Fig. 5. Effect of detelTent on protein adso,ption to plastic tubes. A. Samples
containing isolated GST a in buffer (0.05 M Tris-Ci, pH 7,6) and 0.9%
NaCl were analyzed. Varying amounts of Tween 20, from 0 to 5%, were
added to these samples. Aliquots of the mixture were taken immediately
(•) or after two hours () incubationat + 37°C for quantitation by ELISA.
B. As in A, except that purified GST r was used for analysis.
for the ELISA procedure. We have tested different types of plastic
tubes and all of them, to different extents, adsorbed protein from
the sample. This adsorption could be as high as 80 to 90% of the
total GST protein present. Since we are measuring nanogram
quantities of antigen in the samples, such adsorption may give
completely unreliable results. The most effective way to counter-
act this problem was to add detergent, such as Tween 20, to the
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Table 3. Excretion of GST a and jr in human urine under various
pathological conditions
Diagnosis N
GSTa GSTir
ELISA RIA ELISA MA
ng/ml urine
Healthy control
Cyclosporine A
nephrotoxicity
Renal infarction
Acute rejection of
renal allograft
8
5
2
7
0.9 0.22
101 28
803 125
1.1 0.19
1.1 0.22 5.2 0.74
98 27 5.5 0.83
779 126 311 32
1.4 0.13 42 5.5
5.6 0.77
6.0 0.84
305 40
40 5.8
Samples from patients with certain pathological conditions were se-
lected for analysis as described in the Methods section. For comparison
the same samples were also analysed with our previously described MA.
The values are the mean SEM, N = the number of individuals.
plastic tube before adding the sample. It is also important, with
regards to the properties of the plastic material, to choose
appropriate microtiter plates for the ELISA procedure. It is
necessary that the IgG binds effectively to the plate and is not
liberated during the procedure, and that non-specific adsorption
of the antibody-alkaline phosphatase conjugate to the plate is
minimal. The ELISA procedure for analyzing the levels of the a
and ii• forms of GST in human urine described here provides
sensitive, specific and reproducible data under various conditions.
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